These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38926215)

  • 1. Renal function in PUSH-AHF: a summary of newly released data from the 2024 Annual Congress of the Heart Failure Association of the ESC.
    Yacob AA; Flint KM
    Heart Fail Rev; 2024 Sep; 29(5):945-948. PubMed ID: 38926215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function and natriuresis-guided diuretic therapy - a pre-specified analysis from the PUSH-AHF trial.
    Damman K; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Ter Maaten JM
    Eur J Heart Fail; 2024 Jun; 26(6):1347-1357. PubMed ID: 38734982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
    Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
    Eur J Heart Fail; 2022 Feb; 24(2):385-392. PubMed ID: 34791756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial.
    Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Postmus D; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
    Nat Med; 2023 Oct; 29(10):2625-2632. PubMed ID: 37640861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.
    Cox ZL; Collins SP; Aaron M; Hernandez GA; Iii ATM; Davidson BT; Fowler M; Lindsell CJ; Jr FEH; Jenkins CA; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J
    Am Heart J; 2021 Feb; 232():116-124. PubMed ID: 33144086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'.
    Li K; Shi R; Luo L
    Curr Probl Cardiol; 2024 Aug; 49(8):102688. PubMed ID: 38821235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
    Dauw J; Lelonek M; Zegri-Reiriz I; Paredes-Paucar CP; Zara C; George V; Cobo-Marcos M; Knappe D; Shchekochikhin D; Lekhakul A; Klincheva M; Frea S; Miró Ò; Barker D; Borbély A; Nasr S; Doghmi N; de la Espriella R; Singh JS; Bovolo V; Fialho I; Ross NT; van den Heuvel M; Benkouar R; Findeisen H; Alhaddad IA; Al Balbissi K; Barge-Caballero G; Ghazi AM; Bruckers L; Martens P; Mullens W
    ESC Heart Fail; 2021 Dec; 8(6):4685-4692. PubMed ID: 34708555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure.
    Scatularo CE; Battioni L; Guazzone A; Esperón G; Corsico L; Grancelli HO
    Curr Probl Cardiol; 2024 Aug; 49(8):102674. PubMed ID: 38795800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of urinary sodium assessment in acute heart failure.
    Tersalvi G; Dauw J; Gasperetti A; Winterton D; Cioffi GM; Scopigni F; Pedrazzini G; Mullens W
    Eur Heart J Acute Cardiovasc Care; 2021 Apr; 10(2):216-223. PubMed ID: 33620424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
    Martens P; Chen HH; Verbrugge FH; Testani JT; Mullens W; Tang WHW
    Eur J Heart Fail; 2022 Oct; 24(10):1978-1987. PubMed ID: 36054180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
    Cox ZL; Collins SP; Hernandez GA; McRae AT; Davidson BT; Adams K; Aaron M; Cunningham L; Jenkins CA; Lindsell CJ; Harrell FE; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J
    J Am Coll Cardiol; 2024 Apr; 83(14):1295-1306. PubMed ID: 38569758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study.
    Dauw J; Charaya K; Lelonek M; Zegri-Reiriz I; Nasr S; Paredes-Paucar CP; Borbély A; Erdal F; Benkouar R; Cobo-Marcos M; Barge-Caballero G; George V; Zara C; Ross NT; Barker D; Lekhakul A; Frea S; Ghazi AM; Knappe D; Doghmi N; Klincheva M; Fialho I; Bovolo V; Findeisen H; Alhaddad IA; Galluzzo A; de la Espriella R; Tabbalat R; Miró Ò; Singh JS; Nijst P; Dupont M; Martens P; Mullens W
    Circ Heart Fail; 2024 Jan; 17(1):e011105. PubMed ID: 38179728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure.
    Biegus J; Zymliński R; Sokolski M; Todd J; Cotter G; Metra M; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2019 May; 21(5):624-633. PubMed ID: 30773755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Ter Maaten JM; Rao VS; Hanberg JS; Perry Wilson F; Bellumkonda L; Assefa M; Sam Broughton J; D'Ambrosi J; Wilson Tang WH; Damman K; Voors AA; Ellison DH; Testani JM
    Eur J Heart Fail; 2017 Aug; 19(8):1014-1022. PubMed ID: 28105769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic Resistance in Heart Failure.
    Gupta R; Testani J; Collins S
    Curr Heart Fail Rep; 2019 Apr; 16(2):57-66. PubMed ID: 30762178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial.
    Hodson DZ; Griffin M; Mahoney D; Raghavendra P; Ahmad T; Turner J; Wilson FP; Tang WHW; Rao VS; Collins SP; Mullens W; Testani JM
    JACC Heart Fail; 2019 May; 7(5):383-391. PubMed ID: 31047017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decongestion (instead of ultrafiltration?).
    Schuermans A; Verbrugge FH
    Curr Opin Cardiol; 2024 May; 39(3):188-195. PubMed ID: 38362936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion versus bolus injection of loop diuretics for acute heart failure.
    Rasoul D; Zhang J; Farnell E; Tsangarides AA; Chong SC; Fernando R; Zhou C; Ihsan M; Ahmed S; Lwin TS; Bateman J; Hill RA; Lip GY; Sankaranarayanan R
    Cochrane Database Syst Rev; 2024 May; 5(5):CD014811. PubMed ID: 38775253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.